McInnes, Iain B.
Article History
First Online: 20 March 2020
Competing interests
: I.B.M. receives research grants from Novartis, AstraZeneca, Celgene, Compugen and UCB, as well as honoraria from Novartis, Celgene, Compugen, Galvani Bioelectronics, Eli Lilly and Company, Pfizer, Roche and UCB.
Free to read: This content has been made available to all.